We are the international institution for public private cooperation.
We connect communities of leaders around global issues through high-level meetings, research, initiatives and digital networks. We are non-profit, impartial and independent.
We believe dialogue and cooperation between business, government and civil society can improve the state of the world.
We are a global network of 120+ Impact Hubs spanning 65+ countries across 5 continents, bringing together over 25,000 Impact Makers to drive positive change. Our community is a vibrant collective of entrepreneurs, creators, innovators, and leaders united by a shared mission: to build a regenerative economy where business and profit serve people and the planet.
Our world faces urgent, complex challenges—challenges that demand collaboration and bold solutions. At Impact Hub, we are cultivating an ecosystem for change. By building locally rooted yet globally connected entrepreneurial communities and bridging the gap between large organisations, investors, and public institutions, we enable inclusive and sustainable innovation at scale.
For over 15 years, we’ve been a catalyst for entrepreneurial action. What began in 2005 as a single community in one city has grown into a movement spanning the globe. From Kigali to São Paulo, Taipei to Berlin, we provide access to spaces, resources, networks, knowledge, talent, and investment to transform ideas into impactful action.
The time is now. The way is together. Join us!
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.
The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.